Nano Cancer Barrier Device (Ncbd) To Immobilize And Inhibit The Division Of Metastic Cancer Stem Cells
- Summary
- The Present Invention Provides Methods, Compositions, And Kits Wherein Nanomaterials Are Used For Inhibiting Cancer Stem Cell Division, Colony Formation, Spheroid Formation And Self-Renewal. The Present Invention Also Provides Methods, Compositions, And Kits Wherein Nanomaterials Are Used For Treating Cancer, Coating Tumors, And Inhibiting Metastasis. The Present Invention Also Provides Methods, Compositions, And Kits Wherein Nanomaterials Are Used For Inducing Cells To Go Into Stasis. The Present Invention Further Provides Methods For Isolating Tumors, Inhibiting Bleeding, And Marking Margins Of Tumors And Organs During Surgery With A Nanomaterial.
- Supplementary Information
- Patent Number: US20110144023A1
Application Number: US2010967708A
Inventor: Ellis-Behnke, Rutledge | Ling, Patrick Ming Tat
Priority Date: 14 Dec 2009
Priority Number: US20110144023A1
Application Date: 14 Dec 2010
Publication Date: 16 Jun 2011
IPC Current: A61K003810 | A61P000704 | A61P003500 | C12N000500 | C12Q000102
US Class: 5140137 | 435029 | 435375 | 5140193
Assignee Applicant: The University of Hong Kong
Title: Nano Cancer Barrier Device (NCBD) to Immobilize and Inhibit the Division of Metastic Cancer Stem Cells
Usefulness: Nano Cancer Barrier Device (NCBD) to Immobilize and Inhibit the Division of Metastic Cancer Stem Cells
Summary: The methods are useful for: inducing the cell to go into stasis; inhibiting metastasis of a cancer cell; treating cancer; inhibiting bleeding during and after a surgical procedure; and marking the margins of a tumor (all claimed). Test details are described but no results given.
Novelty: Inducing cell (e.g. prostate cancer stem cell) to go into stasis, useful to treat cancer, comprises contacting exterior of the cell with a nanomaterial, which is a self-assembling peptide
- Industry
- Disease Diagnostic/Treatment
- Sub Category
- Cancer/Tumor
- Application No.
- US2010967708A
- Country/Region
- Hong Kong
For more information, please click Here
